New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 27, 2014
10:51 EDTAPRIApricus Biosciences upgraded to Buy from Hold at Cantor
Cantor Fitzgerald upgraded Apricus Biosciences to Buy citing potential upcoming pipeline catalysts. The firm raised its price target for shares to $3 from $2.50.
News For APRI From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
December 15, 2014
07:35 EDTAPRIApricus Biosciences appoints Barbara Troupin, M.D. as Chief Medical Officer
Subscribe for More Information
December 8, 2014
16:03 EDTAPRIApricus Biosciences files to sell 3.42M share for selling stock holder
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use